These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 9771296

  • 21. The effect of epidural bupivacaine on vecuronium-induced neuromuscular blockade in children.
    Taivainen T, Meretoja OA, Rosenberg PH.
    Acta Anaesthesiol Scand; 1994 Jul; 38(5):453-6. PubMed ID: 7941939
    [Abstract] [Full Text] [Related]

  • 22. [Propofol potentiates the neuromuscular blocking effects of vecuronium in man].
    Watanabe K, Ohmi Y, Adachi H, Satoh T.
    Masui; 2000 Jan; 49(1):2-6. PubMed ID: 10689835
    [Abstract] [Full Text] [Related]

  • 23. Onset and duration of neuromuscular blockade following high-dose vecuronium administration.
    Ginsberg B, Glass PS, Quill T, Shafron D, Ossey KD.
    Anesthesiology; 1989 Aug; 71(2):201-5. PubMed ID: 2569279
    [Abstract] [Full Text] [Related]

  • 24. Effect of smoking on dose requirements for vecuronium.
    Teiriä H, Rautoma P, Yli-Hankala A.
    Br J Anaesth; 1996 Jan; 76(1):154-5. PubMed ID: 8672359
    [Abstract] [Full Text] [Related]

  • 25. Vecuronium is more potent in Montreal than in Paris.
    Fiset P, Donati F, Balendran P, Meistelman C, Lira E, Bevan DR.
    Can J Anaesth; 1991 Sep; 38(6):717-21. PubMed ID: 1680573
    [Abstract] [Full Text] [Related]

  • 26. [Influences of age and gender on dose-response and recovery time-course of atracurium].
    Xue FS, Liao X, He N, Zhang YM, An G.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Feb; 23(1):54-7. PubMed ID: 12905819
    [Abstract] [Full Text] [Related]

  • 27. Normalization of acceleromyographic train-of-four ratio by baseline value for detecting residual neuromuscular block.
    Suzuki T, Fukano N, Kitajima O, Saeki S, Ogawa S.
    Br J Anaesth; 2006 Jan; 96(1):44-7. PubMed ID: 16299046
    [Abstract] [Full Text] [Related]

  • 28. Clinical pharmacology of ORG 7617, a short-acting non-depolarizing neuromuscular blocking agent.
    van den Broek L, Wierda JM, Proost JH, Hommes FD, Agoston S.
    Eur J Clin Pharmacol; 1994 Jan; 46(3):225-9. PubMed ID: 7915236
    [Abstract] [Full Text] [Related]

  • 29. Extending a pipecuronium neuromuscular block. Increments of atracurium or vecuronium as an alternative to pipecuronium.
    Roberts SP, Ramsay TM, Healy TE, Wilson A, Pollard BJ.
    Anaesthesia; 1993 Mar; 48(3):196-9. PubMed ID: 8096370
    [Abstract] [Full Text] [Related]

  • 30. Sevoflurane exposure time and the neuromuscular blocking effect of vecuronium.
    Ahmed AA, Kumagai M, Otake T, Kurata Y, Amaki Y.
    Can J Anaesth; 1999 May; 46(5 Pt 1):429-32. PubMed ID: 10349921
    [Abstract] [Full Text] [Related]

  • 31. Difference in sensitivity to vecuronium between patients with ocular and generalized myasthenia gravis.
    Itoh H, Shibata K, Nitta S.
    Br J Anaesth; 2001 Dec; 87(6):885-9. PubMed ID: 11878691
    [Abstract] [Full Text] [Related]

  • 32. Pharmacodynamic behaviour of vecuronium in primary hyperparathyroidism.
    Roland EJ, Wierda JM, Eurin BG, Roupie E.
    Can J Anaesth; 1994 Aug; 41(8):694-8. PubMed ID: 7923517
    [Abstract] [Full Text] [Related]

  • 33. Age-dependence of the dose-response curve of vecuronium in pediatric patients during balanced anesthesia.
    Meretoja OA, Wirtavuori K, Neuvonen PJ.
    Anesth Analg; 1988 Jan; 67(1):21-6. PubMed ID: 2892436
    [Abstract] [Full Text] [Related]

  • 34. The ulinastatin-induced effect on neuromuscular block caused by vecuronium.
    Saitoh Y, Fujii Y, Oshima T.
    Anesth Analg; 1999 Dec; 89(6):1565-9. PubMed ID: 10589650
    [Abstract] [Full Text] [Related]

  • 35. Is vecuronium a long-acting neuromuscular blocking agent in neonates and infants?
    Meretoja OA.
    Br J Anaesth; 1989 Feb; 62(2):184-7. PubMed ID: 2564279
    [Abstract] [Full Text] [Related]

  • 36. The effect of adenosine triphosphate on vecuronium-induced neuromuscular block.
    Nitahara K, Shono S, Hamada T, Higuchi H, Sakuragi T, Higa K.
    Anesth Analg; 2005 Jan; 100(1):116-119. PubMed ID: 15616064
    [Abstract] [Full Text] [Related]

  • 37. Isobolographic and dose-response analysis of the interaction between pipecuronium and vecuronium.
    Naguib M, Abdulatif M.
    Br J Anaesth; 1993 Oct; 71(4):556-60. PubMed ID: 7903151
    [Abstract] [Full Text] [Related]

  • 38. Evaluation of cumulative properties of three new nondepolarizing neuromuscular blocking drugs BW A444U, atracurium and vecuronium.
    Ali HH, Savarese JJ, Basta SJ, Sunder N, Gionfriddo M.
    Br J Anaesth; 1983 Oct; 55 Suppl 1():107S-111S. PubMed ID: 6134539
    [Abstract] [Full Text] [Related]

  • 39. Sugammadex rapidly reverses moderate rocuronium- or vecuronium-induced neuromuscular block during sevoflurane anaesthesia: a dose-response relationship.
    Pühringer FK, Gordon M, Demeyer I, Sparr HJ, Ingimarsson J, Klarin B, van Duijnhoven W, Heeringa M.
    Br J Anaesth; 2010 Nov; 105(5):610-9. PubMed ID: 20876699
    [Abstract] [Full Text] [Related]

  • 40. Vecuronium-induced neuromuscular block during xenon or sevoflurane anaesthesia in humans.
    Nakata Y, Goto T, Morita S.
    Br J Anaesth; 1998 Feb; 80(2):238-40. PubMed ID: 9602592
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.